Industry veterans Nathaniel "Ned" David, PhD, and Norman "Ned" Sharpless, MD, have launched Jupiter Bioventures, a biotechnology venture foundry aimed at transforming novel science into impactful companies. With the support of multiple new backers, including the CU Healthcare Innovation Fund, the venture plans to advance eight to ten companies focused on developing cancer therapeutics and other related treatments.